Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
MOB.ST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Sales Growth
YoY
Current
Estimates
Return on Equity
QoQ
Institutionnal Ownership
Q2.23
N/A
-0.26
vs -0.06
Q3.23
N/A
-0.36
vs -0.04
Q4.23
N/A
-0.23
vs -0.21
Q1.24
N/A
-0.14
vs -0.34
Q2.24
N/A
-0.13
vs -0.26
Q3.24
N/A
-0.03
vs -0.36
Q4.24
+625%
1.21
vs -0.23
Q1.25
N/A
-0.06
vs -0.14
Q2.25
N/A
-0.10
vs -0.13
Q3.25
N/A
-0.10
vs -0.03
Q2.23
NA
NA vs NA
Q3.23
-100%
NA vs 207K
Q4.23
NA
NA vs NA
Q1.24
NA
820K vs NA
Q2.24
NA
4.1M vs NA
Q3.24
NA
3.9M vs NA
Q4.24
NA
1M vs NA
Q1.25
+372%
3.9M vs 820K
Q2.25
+46%
6M vs 4.1M
Q3.25
+4%
4M vs 3.9M
Q2.23
-1%
-0.01
vs -0.01
Q3.23
-1%
-0.01
vs -0.01
Q4.23
-1%
-0.01
vs -0.01
Q1.24
-1%
-0.01
vs -0.01
Q2.24
0%
-0.00
vs -0.01
Q3.24
0%
-0.00
vs -0.00
Q4.24
-35%
-0.35
vs -0.00
Q1.25
0%
-0.00
vs -0.35
Relative Strength
MOB.ST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
1296%2026-Revenue
-69%2026-EPS
248%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.
STO
0.01Â ( 0.17%)
Relative Strenght
Volume Buzz
-65%
Earning Acce
No
Dist 52w H.
78%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How MOB.ST compares to sector?